Plexāā Wins Prestigious ‘FemTech Product of the Year’ Award for BLOOM⁴³ at MedTech World Awards
Malta, [November 2024] – Plexāā is thrilled to announce that BLOOM⁴³, our groundbreaking device dedicated to reduce wound healing complications after breast surgery, has been awarded “FemTech Product of the Year” at the prestigious MedTech World Awards in Malta. This recognition underscores Plexāā’s unwavering commitment to advancing women’s health through innovative, patient-centered solutions.
Accepting the award on behalf of Plexāā was our Chief Product Officer, Thibault de Becdelievre, whose visionary leadership has been instrumental in driving the innovative, patient-centric design of BLOOM⁴³. Thibault’s dedication, coupled with the tireless efforts of the Plexāā team, has resulted in a product that truly reflects the needs and voices of women worldwide.
“A heartfelt thank you also goes to Carly Moosah and the many other patients who generously shared their experiences and feedback, helping to shape BLOOM⁴³ into a solution that truly transforms lives,” said Dr Saahil Mehta, founder of Plexāā. “This achievement would not have been possible without their invaluable contributions.”
BLOOM⁴³
BLOOM⁴³ represents the essence of Plexāā’s mission: empower every patient to achieve a complication-free experience of surgery, attaining the outcome they want and deserve. This award is a testament to the power of collaboration between patients and innovators in achieving transformative healthcare outcomes.
Plexāā would also like to extend its heartfelt gratitude to MedTech World and to everyone who supported us by casting their votes.
For more information about BLOOM⁴³ and Plexāā commitment to revolutionizing women’s health, visit www.bloom43.com.
About Plexāā
Plexāā is a pioneering UK MedTech company focused on improving surgical outcomes through innovative solutions. Their flagship device, BLOOM⁴³ enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect 1 in 3 women undergoing breast surgery.
BLOOM⁴³ is the world’s first fully wearable device worn next to the skin before breast surgery. By gently warming the area to stimulate the release of Heat Shock Proteins (HSPs). These naturally occurring proteins cause the release of carbon monoxide into the tissue which vasodilates the blood vessels and improves the blood flow to the skin. This improved blood flow primes the skin to heal and has been shown to prevent wound healing complications in proof-of-concept clinical trials.
Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes.
Media Contact: